$AVO

Taylor Bruce C. purchased $3.5M of AVO (indirect holdings)

Taylor Bruce C. purchased 313,590 indirectly-held shares of Mission Produce, Inc. (AVO) at an average of $11.29 ($11.29–$11.40, $3.54M total) across 2 trades over 2026-06-15 to 2026-06-16.

Original reporting
SEC EDGAR · Taylor Bruce C.
Published Jun 17, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AVO
Bullish
medium confidence
Mentioned
$AVO
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVOBullishLow
01

Why it matters

The newest information is the director’s open-market purchase totaling ~$3.54M at an average ~$11.29–$11.40 per share; no 10b5-1 plan is cited.

02

Market read

This is a fresh insider-buy signal for AVO, but it lacks operational or financial catalysts, so trading impact is likely modest.

03

What to watch

Because the trades occurred 1–2 days before filing, the market may have already partially priced any sentiment effect; also, the disclosure is indirect holdings, which can reduce signal strength.

Relevance 7/10Novelty 6/10Timing: Filed 2026-06-17; trades executed 2026-06-15 to 2026-06-16.

Background

The article is an SEC Form 4 insider transaction disclosure for Mission Produce, Inc. (AVO).

Company-level read

Ticker impact

$AVOBullishMedium confidence
Context

Mission Produce director Taylor Bruce bought $3.54M of AVO shares in two open-market trades (6/15–6/16) at ~$11.29–$11.40.

Expected impact

Likely limited near-term impact; any effect should fade unless followed by additional disclosures or operational news.

Evidence & confidence

The filing is a fresh Form 4 and shows director buying, but it does not include guidance, contracts, or other company-changing information.

Market effects

No sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Director buying may reflect diversification or personal liquidity needs rather than a strong forward outlook; without a 10b5-1 plan, timing can still be discretionary.

Key entities

  • Mission Produce, Inc.

    Company whose shares were purchased; Form 4 lists the insider as a director.

  • Taylor Bruce C.

    Director who purchased 313,590 shares in two trades (6/15–6/16) for ~$3.54M, indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AVOMed

Why Mission Produce (AVO) Shares Are Plunging Today

Mission Produce (AVO) shares fell 11.3% after setting 5-year targets: mid-single-digit sales growth, 300 bps margin expansion, and 2035 goals to double sales and triple EBITDA. The company raised Calavo synergy targets to over $30M. Q3 revenue was $450M, up 25.8% YoY, beating estimates. Adjusted EPS was $0.18, a 56.5% beat. Stock is down 4.1% YTD, 27.6% off 52-week high.

$AVOMed

Mission Produce Unveils Five-Year Financial Targets and Strategies at 2026 Investor Day

Mission Produce (AVO) hosted its 2026 Investor Day, outlining five-year targets: mid-single-digit organic sales growth, 300 basis points of margin expansion, and 90% cash conversion. The company aims to double sales and triple Adjusted EBITDA by 2035, supported by Calavo integration, Prepared Foods expansion, and asset utilization. Management expects high-single-digit to double-digit annual shareholder returns.

$AVOMed

Mission Produce unveils five-year targets, $100M buyback, aims to double sales and triple EBITDA by 2035

Mission Produce announced a five-year plan with mid-single-digit organic sales growth, 300bps margin expansion, and 2035 targets to double sales to $4B and triple Adjusted EBITDA to $450M. The company reaffirmed fiscal 2H26 Adjusted EBITDA outlook of $84–88M and Q426 Adjusted EBITDA of $52–55M. It also launched a $100M share repurchase program, with 290,994 shares repurchased at an average price of $12.94.

$AVOMedAI 8/10

Acquisition Momentum Offset by Profitability Headwinds for Mission Produce (AVO)

Mission Produce (AVO) reported Q3 FY26 adjusted EBITDA of $32.4M, beating expectations. Revenue rose 26% YoY to $450M, driven by avocado supply growth and the Calavo acquisition. However, profitability declined, with adjusted net income down YoY. Q4 adjusted EBITDA is projected at $52M-$55M, incorporating Calavo benefits. Institutional investment remained steady, with 20 hedge funds holding shares.